Advanced Oncotherapy (LSE:AVO) ROE % Adjusted to Book Value : -29.60% (As of Jun. 2022)

View and export this data going back to 2006. Start your Free Trial

What is Advanced Oncotherapy ROE % Adjusted to Book Value?

Advanced Oncotherapy's ROE % for the quarter that ended in Jun. 2022 was -52.10%. Advanced Oncotherapy's PB Ratio for the quarter that ended in Jun. 2022 was 1.76. Advanced Oncotherapy's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2022 was -29.60%.

Advanced Oncotherapy ROE % Adjusted to Book Value Historical Data

The historical data trend for Advanced Oncotherapy's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Oncotherapy ROE % Adjusted to Book Value Chart

Advanced Oncotherapy Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-26.91

-34.10

-23.81

-21.29

-20.04

Advanced Oncotherapy Semi-Annual Data
	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-32.93	-20.51	-19.11	-24.55	-29.60

Competitive Comparison of Advanced Oncotherapy's ROE % Adjusted to Book Value

For the Medical Devices subindustry, Advanced Oncotherapy's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Advanced Oncotherapy's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Advanced Oncotherapy's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Advanced Oncotherapy's ROE % Adjusted to Book Value falls into.

Advanced Oncotherapy ROE % Adjusted to Book Value Calculation

Advanced Oncotherapy's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2021 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-55.91%	/	2.79
	=	-20.04%

Advanced Oncotherapy's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2022 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-52.10%	/	1.76
	=	-29.60%

Advanced Oncotherapy ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Advanced Oncotherapy's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Advanced Oncotherapy (LSE:AVO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Advanced Oncotherapy PLC (LSE:AVO) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

4 Tenterden Street, Third Floor, London, GBR, W1S 1TE

Website

https://www.avoplc.com

Advanced Oncotherapy PLC is active in the healthcare domain in the United Kingdom. As a medical care provider, its focus is to develop technologies to maximize the destructive effect of radiation on tumors whilst minimizing damage to healthy tissues. It develops an affordable proton-based radiotherapy system, using innovative and clinically effective technology, thereby contributing to curing critical unmet conditions. The company's only business segment is Proton Therapy.